Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2007

01-03-2007 | Epidemiology

Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women

Authors: Martha L. Slattery, Carol Sweeney, Sandra Edwards, Jennifer Herrick, Kathy Baumgartner, Roger Wolff, Maureen Murtaugh, Richard Baumgartner, Anna Giuliano, Tim Byers

Published in: Breast Cancer Research and Treatment | Issue 1/2007

Login to get access
Metadata
Title
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women
Authors
Martha L. Slattery
Carol Sweeney
Sandra Edwards
Jennifer Herrick
Kathy Baumgartner
Roger Wolff
Maureen Murtaugh
Richard Baumgartner
Anna Giuliano
Tim Byers
Publication date
01-03-2007
Published in
Breast Cancer Research and Treatment / Issue 1/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9292-y

Other articles of this Issue 1/2007

Breast Cancer Research and Treatment 1/2007 Go to the issue

PRE-CLINICAL STUDY

Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer

Preclinical Study

Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines

EPIDEMIOLOGY

Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases

Clinical Trial

Monitoring primary breast cancer throughout chemotherapy using FDG-PET

Epidemiology

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

Letter to the Editor

Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits